Preclinical profile and phase I clinical trial of a novel androgen receptor antagonist GT0918 in castration-resistant prostate cancer
2008 ◽
2021 ◽
Vol 64
(2)
◽
pp. 909-924
◽
2019 ◽
Vol 234
(9)
◽
pp. 15472-15486
◽